Literature DB >> 28984668

Brain-Heart Interactions in Traumatic Brain Injury.

Ayman El-Menyar1, Abhishek Goyal, Rifat Latifi, Hassan Al-Thani, William Frishman.   

Abstract

The cardiovascular manifestations associated with nontraumatic head disorders are commonly known. Similar manifestations have been reported in patients with traumatic brain injury (TBI); however, the underlying mechanisms and impact on the patient's clinical outcomes are not well explored. The neurocardiac axis theory and neurogenic stunned myocardium phenomenon could partly explain the brain-heart link and interactions and can thus pave the way to a better understanding and management of TBI. Several observational retrospective studies have shown a promising role for beta-adrenergic blockers in patients with TBI in reducing the overall TBI-related mortality. However, several questions remain to be answered in clinical randomized-controlled trials, including population selection, beta blocker type, dosage, timing, and duration of therapy, while maintaining the optimal mean arterial pressure and cerebral perfusion pressure in patients with TBI.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28984668     DOI: 10.1097/CRD.0000000000000167

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  7 in total

Review 1.  Biomarkers for traumatic brain injury: a short review.

Authors:  Marcela Usberti Gutierre; João Paulo Mota Telles; Leonardo Christiaan Welling; Nícollas Nunes Rabelo; Manoel Jacobsen Teixeira; Eberval Gadelha Figueiredo
Journal:  Neurosurg Rev       Date:  2020-10-19       Impact factor: 3.042

Review 2.  Bypassing TBI: Metabolic Surgery and the Link between Obesity and Traumatic Brain Injury-a Review.

Authors:  T W McGlennon; J N Buchwald; Walter J Pories; Fang Yu; Arthur Roberts; Eric P Ahnfeldt; Rukmini Menon; Henry Buchwald
Journal:  Obes Surg       Date:  2020-10-30       Impact factor: 4.129

3.  Significance of Cardiac Troponin I Elevation in Traumatic Brain Injury Patients.

Authors:  Siamak Rimaz; Ali Ashraf; Shideh Marzban; Mohammad Haghighi; Seyyed Mahdi Zia Ziabari; Gelareh Biazar; Sheyda Rimaz; Samad Omidi
Journal:  Anesth Pain Med       Date:  2019-04-28

4.  iTRAQ-based proteomic profiling reveals protein alterations after traumatic brain injury and supports thyroxine as a potential treatment.

Authors:  Zhongxiang Zhang; Jiangtao Yu; Pengcheng Wang; Lian Lin; Ruining Liu; Rong Zeng; Haoli Ma; Yan Zhao
Journal:  Mol Brain       Date:  2021-01-27       Impact factor: 4.041

5.  Decompressive Craniectomy Improves QTc Interval in Traumatic Brain Injury Patients.

Authors:  Wojciech Dabrowski; Dorota Siwicka-Gieroba; Chiara Robba; Rafael Badenes; Katarzyna Kotfis; Todd T Schlegel; Andrzej Jaroszynski
Journal:  Int J Environ Res Public Health       Date:  2020-11-21       Impact factor: 3.390

6.  Beta blocker use in traumatic brain injury based on the high-sensitive troponin status (BBTBBT): methodology and protocol implementation of a double-blind randomized controlled clinical trial.

Authors:  Ayman El-Menyar; Mohammad Asim; Ahmed Abdel-Aziz Bahey; Talat Chughtai; Abdulnasser Alyafai; Husham Abdelrahman; Sandro Rizoli; Ruben Peralta; Hassan Al-Thani
Journal:  Trials       Date:  2021-12-07       Impact factor: 2.279

Review 7.  Endothelial glycocalyx in traumatic brain injury associated coagulopathy: potential mechanisms and impact.

Authors:  Zhimin Zou; Li Li; Nadine Schäfer; Qiaobing Huang; Marc Maegele; Zhengtao Gu
Journal:  J Neuroinflammation       Date:  2021-06-14       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.